⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACTU News
Actuate Therapeutics, Inc. Common stock
Actuate Therapeutics Phase 2 Metastatic Pancreatic Cancer Data Selected for Oral and Poster Presentation at ASCO GI 2026
globenewswire.com
ACTU
Actuate Therapeutics Announces Publication of Positive Phase II Clinical Data for Elraglusib Combined with Platinum Chemotherapy and Sequential Immunotherapy in Recurrent, Metastatic Salivary Gland Carcinoma
globenewswire.com
ACTU
WISCONSIN TEAMSTERS AUTHORIZE STRIKES AT ACTUS NUTRITION AND FOREMOST FARMS
prnewswire.com
ACTU
Actuate Therapeutics Advances a New Era in Oncology with Potential Universal Backbone Therapy
accessnewswire.com
ACTU